Background: Maternal obesity, excessive gestational weight gain (GWG) and rapid weight gain (RWG) in infancy are found to be modifiable risk factors of obesity and non-communicable diseases in children. The lack of long-term sustainability and the cost of secondary prevention of obesity urge for action to identify strategies for primary and primordial prevention.
Aims: Our aim is to summarize the wealth of evidence from human as well as animal studies on the mechanistic role of maternal obesity and GWG on offspring adiposity and plausible preventive interventions at individual as well as community level.
Review Results: Maternal factors like obesity, nutrition, lifestyle and GWG can alter the intrauterine milieu that result in DNA methylation of fetal metabolic genes and exposure of the developing fetus to abnormal levels of leptin and adiponectin. Community-wide research from western countries show that postpartum weight reduction, antenatal lifestyle modifications, physical activity during pregnancy and early lifestyle interventions during the first two years of life are effective in preventing childhood obesity.
Conclusion: Epigenetic modifications and adipokines play a pivotal role in the maternal-offspring transmission of obesity risk. In addition, RWG in infancy leads to later childhood obesity. Interventions to achieve normal preconceptual BMI, GWG and prevent RWG in infancy have the potential to prevent the development of obesity.
Clinical Significance: Globally, prevention of childhood obesity should focus on identification of cost-effective, feasible and sustainable programs. Research from low and low-middle-income (LMI) countries are expected to contribute to the policy-makers on development of an appropriate framework to be implemented at ground level.
Keywords: childhood obesity, maternal obesity, gestational weight gain, DNA methylations, adipokines, rapid weight gain in infancy, obesity prevention
INTRODUCTION
The rising prevalence of obesity in children and adults is a
global health concern1. Obesity has been determined as a key factor in the
etiology of several non-communicable diseases (NCD) including cardiovascular
disease, type 2 diabetes, non-alcoholic steatohepatitis and several types of
cancer1. The persistence of childhood obesity with its associated
metabolic derangements into adulthood is widely evident2.
Childhood obesity also induces a significant personal, societal
and economic burden at local as well as global level3.
While the increasing trends of body mass index (BMI) have
plateaued in most of the high-income countries, the obesity prevalence
continues to escalate in the low and low-middle income countries particularly
in East and South Asia for both sexes, and Southeast Asia for boys4.
At present, management of childhood overweight and obesity is based on
lifestyle modification interventions. Most studies published to date have
demonstrated either a low or short-term positive effect4,5. In
addition, management of obesity and associated complications involve a large
health care cost per person apart from loss of income at both individual and
societal level over a lifetime, indicating the need for cost-effective
preventive strategies. Hence, it is important to elucidate the origins of
obesity and identify the opportunities to prevent its occurrence both at
primary and primordial levels.
While the western lifestyle with high fat, high sugar diet with
refined carbohydrates and sedentary behavior are thought to contribute to the
global shift towards an obese phenotype, strong evidence has emerged to support
that the developmental origins of obesity as well as metabolic syndrome are
linked with in utero programming of metabolic genes. Maternal obesity and
increased GWG are considered to adversely influence the intrauterine
environment3,6,7.
The aim of this review is to summarize the evidence for the
association between maternal factors such as BMI and GWG with offspring
adiposity and to explore potential mechanisms mediating this relationship. We
also highlight the possible interventions available to modulate the early
origins of childhood obesity.
The recently published WHO report on ―Ending childhood obesity‖ reflects that those specific opportunities for effective prevention of obesity and associated NCDs exist at different stages in the life cycle namely pre-pregnancy and pregnancy, infancy and early childhood, and adolescence which is also the pre-pregnancy period for girl child3.
Impact of maternal obesity on offspring adiposity and cardiometabolic
risk
Maternal BMI at the time of conception has been identified across
several studies as a strong predictor of offspring adiposity8,9,10.
A meta-analysis carried out by analyzing data from 162,129 mothers and their
offspring from 37 pregnancy and birth cohort studies from Europe, North
America, and Australia11, identified that higher maternal
pre-pregnancy BMI and gestational weight gain were associated with an increased
risk of childhood overweight/obesity, with the strongest effects seen at later
ages of childhood.
Increased prevalence of adult obesity has resulted in higher BMI
among pre-pregnant females. A significant proportion of women, entering
pregnancy, also suffer from non-communicable diseases such as Type II diabetes
mellitus and hypertension which can affect the intrauterine environment of the
growing fetus12. Higher maternal BMI increases the risk for both large and
small for gestational age babies (LGA and SGA) whereas low maternal BMI is
associated with small for gestational age babies (SGA)13,14. Both
high and low birth weights are known to be associated with childhood obesity
and metabolic syndrome
World Health Organization (WHO) reports that the prevalence of
obesity during pregnancy ranges from 1.8% to 25.3% 1. According to
the European Perinatal Health Report more than 30% of pregnant women are obese
in most European countries15. A global estimation of overweight and obesity in
pregnant women based on panel data between 2005 and 2014 reported that India
has the highest percentage of overweight and obese females. China also had 1.06
million obese pregnant women, and the number increased by 71.2% within ten
years16.
The prevalence of overweight and obesity among Sri Lankan women
have been reported by the WHO as 26.8% and 7.4% respectively. However, there
are no published data among women of child bearing age17.
Evidence has accumulated over the years to prove that higher
maternal BMI and increased GWG are independently associated with offspring
adiposity during early childhood18,19. Starling et al estimated the
associations of maternal pre-pregnancy BMI and increased GWG at different
periods of pregnancy with neonatal adiposity20. They concluded that
maternal pre-pregnancy BMI, overall and period specific (early, mid and late pregnancy)
GWG, were positively and independently associated with neonatal adiposity.
The mechanistic role of maternal obesity in fetal metabolism
While the association between maternal BMI and offspring adiposity
is well established, the exact mechanisms mediating this relationship are still
not clear.
Maternal obesity potentially influences the fetal growth via mechanisms induced by an altered genetic, biochemical and hormonal environment. Evidence has accumulated to prove that adipokines and epigenetic changes of fetal metabolic genes play a pivotal role in the causal pathway of childhood obesity21.
Figure 1: Postulate causal mechanisms of increased adiposity in
offspring of obese mothers
Obesity during pregnancy is characterized by a state of
hyperglycemia, hypertriglyceridemia and hyperinsulinemia associated with
insulin resistance. This altered endocrine milieu results in increased plasma
levels of free fatty acids, hence placental transfer and enhancement of fetal
fat deposit22.
Studies have shown that gestational weight gains both greater and lesser than the Institute of Medicine (IOM) recommendation have adverse metabolic effects on the offspring, irrespective of the pre-pregnancy BMI. Tam et al observed a ‘U’ shape relationship between maternal gestational weight gain and increased risk of insulin resistance, hypertension and low insulin sensitivity index in children whose mothers had gestational weight gains out of the IOM recommended range irrespective of the pre-pregnant BMI23.
Table 1: Association between maternal adiposity markers / cord
blood adipokines with offspring metabolic markers
Cord
blood adipokines and offspring obesity
Adipose tissue is now recognized as an endocrine organ, which
secretes numerous bioactive peptides known as adipokines24.
These adipokines have numerous roles in metabolic regulation
including blood glucose homeostasis and energy balance regulation. Leptin is an
adipokine which is important in regulation of body weight via regulation of
appetite and energy expenditure. Cord blood leptin is recognized widely as an
accurate biomarker of neonatal adiposity. In pregnancy, leptin is important in
regulating satiety and energy metabolism and placentation. Adiponectin, an
insulin-sensitizing adipokine, is less well studied than leptin. Maternal
obesity is characterized by high leptin with low adiponectin levels.
Increased GWG is also associated with higher umbilical cord blood
leptin levels independent of pregestational BMI status25. Low levels
of adiponectin have shown to be associated with increased fetal growth26.
Animal studies have shown that administration of adiponectin
causes reduction in placental nutrient transfer by downregulating the
expression of placental nutrient transporters. Adiponectin also inhibits the
insulin/IGF-1 signaling mechanism27. A positive correlation between
maternal and cord blood hyperleptinaemia with offspring adiposity has been
demonstrated across several studies. However, there are studies that have
revealed either a weak or absence of such correlation. Most of the studies have
had small sample sizes. Table 1 summarizes the studies that have evaluated the
association of maternal and cord blood adipokines with offspring adiposity.
The Avon longitudinal study of parents and children (ALSPAC study)
is the largest published study to date which is a UK birth cohort followed up
to 17 years of age. It showed that higher cord blood leptin levels were
associated with higher z-scores of fat mass, waist circumference and BMI at 9 years
of age. However, they concluded that the association was weak34. The
study conducted by Shekhawat et al found that both LGA and IUGR infants were
hyperleptinaemic32. Further studies are expected to enhance the
understanding of the long-term effects of adipokines on offspring health and
the interventions to minimize these effects.
Epigenetics
and offspring adiposity
Epigenetics, the study of modifications to DNA that alter gene
expression without changing gene sequence has been identified as another
mechanism contributing to the early life development of excess adiposity and an
adverse metabolic phenotype35.
Epigenetic processes alter the openness of the transcriptional
machinery to a particular gene, thereby determining whether the gene is active
in a given cell at a given time or not. Another important fact is that although
the DNA sequence of genes in an individual (the genome) is largely stable, the
epigenome has the potential to be reversibly modified by exposure to a range of
nutritional and environmental factors. Recent research has shown that maternal
obesity, excessive GWG, maternal glycaemia, nutritional quality and physical
activity during pregnancy are potential contributors of epigenetic changes
(Table 2).
Intrauterine exposure to high levels of lipids as well as
oxidative stress can lead to epigenetic changes in fetal metabolic genes that
induce obesity in the offspring and related diseases later in life36,37,38,39.
Table 2 summarizes the association of DNA methylation with maternal factors and
offspring health.
Two recently published studies have focused on the impact of
maternal nutrition before and during pregnancy on DNA methylation in the
offspring40. The first study used a Gambian mother-child cohort to
show that maternal malnutrition was associated with altered DNA methylation of
growth and metabolism related genes in the infants41. The second
study applied adult offspring from the Dutch Hunger Winter cohort to
investigate the effect of prenatal exposure to an acute period of severe
maternal under nutrition on DNA methylation of genes involved in growth and
metabolism in adulthood. The results highlighted that the impact on the
epigenome was significant with exposure during early gestation.
The UK newborn epigenetics study (NEST) that was conducted to
determine the effect of maternal pre pregnancy obesity and fetal DNA
methylation on offspring metabolic health revealed that methylation of multiple
CpG sites of the TAPBP were associated with higher blood pressure centiles at
4-5 years of age, though the results did not reach statistical significance42.
Table 2: Association between maternal factors with cord blood DNA
methylation and offspring adiposity
Association of maternal lifestyle factors with offspring adiposity
Regular physical activity during pregnancy is shown to be
associated with improved fetal growth. A meta-analysis of randomized controlled
trials show that supervised prenatal exercises reduce the odds of having a
large for gestational age baby by 31% 50. McCullough et al explored
the association between prenatal physical activity, birth weight and offspring
DNA methylation of metabolic genes among 484 mother-infant pairs. They found
that infants born to mothers with longer non-sedentary times had lower birth
weights compared to mothers with shorter non-sedentary times. The study also
gives evidence that maternal physical activity leads to epigenetic changes of
the fetus that potentially improve long-term health of the offspring47.
Anna Telschow et al30 has reported that the cord blood leptin level
is influenced by maternal physical activity. Therefore, they suggest that an
active and healthy maternal lifestyle may play a pivotal and beneficial role in
the offspring’s weight development. However, larger studies are needed to
provide further understanding on the effect of maternal lifestyle on offspring
adiposity and metabolic health.
The association between postnatal growth acceleration and
childhood obesity
Rapid postnatal weight gain particularly during infancy and the
second year of life has shown to be associated with later obesity 51,52.
The UK Millennium Cohort study (n=10,637) demonstrated higher BMI
trajectories in children who experienced rapid weight gain in early life53.
While epigenetic mechanisms have been implicated in the development of NCDs in
later life through fetal programming, recent epidemiological research points
out that nutritional manipulation during early infancy could prevent
accelerated post-natal growth and associated adverse metabolic health outcomes 54.
The 1990 IOM report placed an emphasis on birth outcomes that are
chiefly related to low birth weight, which was a particular concern at that
time and infant nutrition was focused more on achieving catch up growth. Catch
up growth in SGA infants is defined as achieving a height at 2 years of age of
more than -2SD for chronological age 55.
Clinical trials done on preterm as well as term newborn infants
have suggested that nutrient-enriched, calorie dense diet is associated with
rapid post-natal growth and later development of insulin resistance and high
blood pressure 56,57. Therefore, the current trend in early
childhood nutrition has moved towards the impact on the long-term health
outcomes rather than weight gain alone 58.
Prevention of childhood obesity through early life interventions
The aim of this review is to highlight the importance and the
windows of opportunity that exists during the pre-conceptual period, pregnancy
and postnatal life to apply well designed interventions to modulate the early
origins of childhood obesity.
Figure 2 shows some of the plausible strategies that have shown
potential to modify the unfavourable trajectories during these critical periods
of life.
Figure 2: Strategic prevention of childhood obesity through
interventions during the periods of developmental plasticity
Implementation of such preventive measures will need a
well-planned integrated multicomponent approach involving multiple stakeholders
through re-setting of societal standards 59,60.
Interventions
to prevent pre-conceptual obesity
The affliction of a fate of later-life risk of obesity upon the
newborn infant creates a vicious cycle at epidemic level. Therefore, prevention
of maternal obesity takes priority in reversing the tide on the obesity
epidemic. Systematic reviews on diet and lifestyle interventions and drugs like
metformin to manage weight during pregnancy have not shown promising outcomes,
highlighting that the interventions during the 2nd and 3rd trimesters of pregnancy
could be too late 61,62. Prevention of maternal obesity should
therefore focus on the reduction of BMI prior to conception. Post-partum period
can be considered as a window of opportunity to implement weight
control/reduction interventions and encourage women to obtain a healthy BMI
prior to the next pregnancy. The basis behind this is, obesity associated
lipogenesis and adipose tissue inflammation that leads to altered intrauterine
metabolic and endocrine milieu start in the first trimester itself, meaning
that, interventions in later stages of pregnancy may be rather too late to be
effective 63. Randomized controlled trials exploring the possible
impact of antenatal lifestyle modification on offspring’s birthweight and
infant adiposity showed a significant reduction in the number of high birth
weight newborns and reduced subscapular skinfold thickness at 6 months of age 64
.
In 2009, the IOM revised the GWG guidelines, on the basis of the
incidence of obesity in the reproductive age. The recommendation was to
primarily meet the obligatory accrual of water and protein 65. The
IOM allows interventions to reduce weight during lactation and states that
losing as much as 2kg/month does not affect the milk volume but daily energy
restriction should not exceed 1800 kcal. Studies have shown that such weight
loss can safely be achieved in obese lactating women by an energy deficit of
500kcal/ day along with 4 days per week of aerobic exercises 66,67,68,69.
Current recommendations from western countries include supervised
weight reduction prior to conception and bariatric surgery. The application of
these interventions to low- and middle-income countries need further evaluation
considering the availability of expertise and facilities 70,71.
Interventions
to prevent rapid weight gain in infancy
Exclusive breast feeding within the first 6 months of life is
considered with high priority in obesity prevention. Many studies have revealed
that the benefit of breast milk is not only nutritional, but rather has
biological effects that influence an individual’s long-term health and
development. Breast feeding in comparison to formula feeding has an attenuating
effect on increased weight gain and this protective effect of breast feeding on
later obesity has been repeatedly shown across the studies 72,73.
The effect of the timing and composition of complementary feeding
on childhood obesity have not been elucidated yet. However, avoiding over
feeding and excess energy consumption are important in preventing high weight
gain during complementary feeding.
The baseline results of the NOURISH randomized trial on feeding
intervention to prevent RWG identified formula feeding and feeding to schedule
as modifiable risk factors 74.
Similarly, lifestyle interventions addressing nutrition and
physical activity during early life particularly in infants who were exposed to
adverse intrauterine conditions would potentially prevent accelerated weight
gain and future risk of obesity. The US “INSIGHT” randomized controlled trial
that assessed the effectiveness of responsive parenting on preventing RWG,
revealed a significant slowing of weight gain in the intervention group 75.
Together, the available evidence points out the potential of
nutritional manipulation in early years in the prevention of later obesity.
The way forward to prevent childhood obesity
Low and middle-income countries need to take prevention of
childhood obesity with high priority due to the foreseeable scale of burden of
NCD in this region. The BMI cut-offs for the Asian population may affect the
policy-making in these communities. Considering the variations in body
compositions between ethnicities and the higher prevalence of gestational
diabetes at a relatively low BMI for Asian populations, WHO is yet to endorse
lower criteria for the classification of obesity in Asian women 76,77. Additionally, the relationship between
metabolically healthy obesity in pregnancy and offspring health need further
evaluation 78.
It appears that interventions during the preconceptual period,
pregnancy and the first two years of life can have a considerable impact on
childhood obesity. A latest review of prenatal interventions states that
initiation of combined interventions early in pregnancy may decrease adiposity
in the offspring 79.
However, information is lacking on preventive strategies from low
and low-middle income countries which should be developed based on further
research in their own communities.
Obesity being a public health problem spread across all types of
communities, lifestyle modification will remain the mainstay of treatment and
prevention. Bariatric and metabolic surgery may not be an attractive option in
most LMI countries due to lack of facilities and expertise. National level
implementation of policies through governmental leadership to reform obesogenic
environments, attitudes towards healthy eating and physical activity of
children would pave the way towards permanent societal changes 80,81.
Finally, the most cost-effective approach to curb the obesity
epidemic and strengthen the human capacity would be to establish a robust
preventive program focusing on primordial prevention which could not only
prevent childhood obesity, but also build up a metabolically healthier adult
population.
Our intension through this review is to encourage community-wide
research from LMI countries to explore the best ways for primordial prevention
of child hood obesity.
REFERENCES
1. World Health Organization.
Overweight and Obesity. Available online
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
(Accessed on 10 March 2020).
2. Maffeis C, Tatò L. Long-term
effects of childhood obesity on morbidity and mortality. Hormone Pediatr. Res.
2001;55(1):42-5.
3. Commission on Ending Childhood Obesity. Report of the Commission on Ending Childhood Obesity. Geneva, Switzerland: World Health Organization; 2016.
4. Metcalf B, Henley W, Wilkin T.
Effectiveness of intervention on physical activity of children: systematic
review and meta-analysis of controlled trials with objectively measured
outcomes (EarlyBird 54). BMJ. 2012; 345:5888.
5. Wieland LS, Falzon L,
Sciamanna CN, Trudeau KJ, Folse SB, Schwartz JE, et al. Interactive
computer-based interventions for weight loss or weight maintenance in
overweight or obese people. The Cochrane database of systematic reviews. 2012;
8:CD007675.
6. Ho M, Garnett SP, Baur L,
Burrows T, Stewart L, Neve M, Collins C. Effectiveness of lifestyle
interventions in child obesity: systematic review with meta-analysis.
Pediatrics. 2012;130(6):e1647-71.
7. Woo Baidal JA, Locks LM, Cheng
ER, et al. Risk factors for childhood obesity in the first 1,000 days: a
systematic review. Am J Prev Med.2016; 50:761–779.
8. Yu Z, Han S, Zhu J, Sun X, Ji
C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and
offspring overweight/obesity: a systematic review and meta-analysis. PloS one.
2013;8(4):e61627.
9. Gaillard R, Steegers EA,
Duijts L, Felix JF, Hofman A, Franco OH, Jaddoe VW. Childhood cardiometabolic
outcomes of maternal obesity during pregnancy: the Generation R Study.
Hypertension. 2014;63(4):683-91.
10. Fraser A, Tilling K,
Macdonald-Wallis C, Sattar N, Brion MJ, Benfield L, et al. Association of
maternal weight gain in pregnancy with offspring obesity and metabolic and
vascular traits in childhood. Circulation. 2010 15;121(23):2557-64.
11. Voerman E, Santos S,
PatroGolab B, et al. Maternal body mass index, gestational weight gain, and the
risk of overweight and obesity across childhood: an individual participant data
meta-analysis. PLoS Med 2019; 16:e1002744.
12. Poston L. Maternal obesity,
gestational weight gain and diet as determinants of offspring long term health.
Best Pract. Res. Clin. Endocrinol. Metab. 2012; 26(5):627-39
13. Ehrenberg HM, Dierker L,
Milluzzi C, Mercer BM. Low maternal weight, failure to thrive in pregnancy, and
adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 2003;189(6):1726-30
14. Hong YH, Chung S. Small for
gestational age and obesity related comorbidities. Ann Pediatr Endocrinol
Metab. 2018;23(1):4.
15. Euro-Peristat Project.
European Perinatal Health Report. Core Indicators of the Health and Care of
Pregnant Women and Babies in Europe in 2015. 2018. Available online:
https://www.europeristat.com/images/ EPHR2015_web_hyperlinked_Euro-Peristat.pdf
(Accessed on 15 March 2020).
16. Chen C, Xu X, Yan Y. Estimated
global overweight and obesity burden in pregnant women based on panel data
model. PloS one. 2018;13(8):e0202183.
17. World Health Organization. (2018). Noncommunicable diseases
country profiles 2018. World Health Organization.
https://apps.who.int/iris/handle/10665/274512. (Accessed on 15 March 2020).
18. Chiavaroli V, Hopkins SA,
Biggs JB, Rodrigues RO, Seneviratne SN, Baldi JC, et al. The associations
between maternal BMI and gestational weight gain and health outcomes in
offspring at age 1 and 7 years. Sci. Rep. 2021;11(1):1-0.
19. Tie HT, Xia YY, Zeng YS, Zhang
Y, Dai CL, Guo JJ, Zhao Y. Risk of childhood overweight or obesity associated
with excessive weight gain during pregnancy: a meta-analysis. Arch. Gynecol.
Obstet. 2014;289(2):247-57.
20. Starling AP, Brinton JT,
Glueck DH, Shapiro AL, Harrod CS, Lynch AM, et al. Associations of maternal BMI
and gestational weight gain with neonatal adiposity in the Healthy Start
study. Am. J. Clin. Nutr..
2015;101(2):302-9.
21. Tenenbaum-Gavish K, Hod M.
Impact of maternal obesity on fetal health. Fetal. Diagn. Ther. 2013;34(1):1-7.
22. Herrera E, Amusquivar E. Lipid
metabolism in the fetus and the newborn. Diabetes Metab J. 2000;16(3):202-10.
23. Tam CH, Ma RC, Yuen LY, Ozaki
R, Li AM, Hou Y, et al. The impact of maternal gestational weight gain on cardiometabolic
risk factors in children. Diabetologia. 2018;61(12):2539-48.
24. Kershaw EE, Flier JS. Adipose
tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004;89(6):2548-56.
25. Vargas-Aguirre P, Tene CE, Del
Toro-Equihua M, Bayardo-Tortolero R, Sánchez-Meza K. Comparison of leptin
levels in neonates born to mothers with high or low gestational weight gain. J.
Pediatr. Endocrinol. Metab. 2020;33(4):517-23.
26. Aye IL, Powell TL, Jansson T.
adiponectin–the missing link between maternal adiposity, placental transport
and fetal growth. Placenta. 2013;34:S40-5.
27. Josefson JL, Zeiss DM,
Rademaker AW, Metzger BE. Maternal leptin predicts adiposity of the neonate.
Horm. Res. Paediatr. 2014;81(1):13-9.
28. Catalano PM, Presley L, Minium
J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in
utero. Diabetes care. 2009;32(6):1076-80.
29. Telschow A, Ferrari N, Deibert
C, Flöck A, Merz WM, Gembruch U, et al. High Maternal and Low Cord Blood Leptin
Are Associated with BMI-SDS Gain in the First Year of Life. Obes. Facts. 2019;
12(5):575-85.
30. Boeke CE, Mantzoros CS, Hughes
MD, L. Rifas‐Shiman S, Villamor E, Zera CA, Gillman MW. Differential
associations of leptin with adiposity across early childhood. Obesity. 2013;
21(7):1430-7.
31. Shekhawat PS, Garland JS,
Shivpuri C, Mick GJ, Sasidharan P, Pelz CJ, McCormick KL. Neonatal cord blood
leptin: its relationship to birth weight, body mass index, maternal diabetes,
and steroids. Pediatr. Res. 1998;43(3):338-43.
32. Karakosta P, Georgiou V,
Fthenou E, Papadopoulou E, Roumeliotaki T, Margioris A, et al. Maternal Weight
Status, Cord Blood Leptin and Fetal Growth: a Prospective Mother–Child Cohort
Study (R hea Study). Paediatr. Perinat. Epidemiol. 2013;27(5):461-71.
33. Haghiac M, Basu S, Presley L,
Serre D, Catalano PM, Hauguel-de Mouzon S. Patterns of adiponectin expression
in term pregnancy: impact of obesity. J. Clin. Endocrinol. Metab.
2014;99(9):3427-34.
34. Simpson J, Smith AD, Fraser A,
Sattar N, Lindsay RS, Ring SM, et al. Programming of adiposity in childhood and
adolescence: associations with birth weight and cord blood adipokines. J. Clin.
Endocrinol. Metab. 2017; 102(2):499-506.
35. Desai M, Jellyman JK, Ross MG.
Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes
(Lond). 2015; 39(4):633–41.
36. Furukawa S, Fujita T,
Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress
in obesity and its impact on metabolic syndrome. J. Clin. Investig.
2017;114(12):1752-61.
37. Williams CB, Mackenzie KC,
Gahagan S. The effect of maternal obesity on the offspring. ClinObstet Gynecol.
2014;57(3):508-15.
38. Vos MB. Furthering the
understanding of maternal obesity in nonalcoholic fatty liver disease. Hepatology.
2013;58(1):4- 5.
39. Heerwagen MJ, Miller MR,
Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a
fertile epigenetic soil. American Journal of Physiology-Regulatory. Integr.
Comp. Biol. 2010;299(3):R711-22.
40. Gagné-OuelletV,Breton E,
Thibeault K, Fortin CA, Cardenas A, Guérin R, et al. Mediation analysis
supports a causal relationship between maternal hyperglycemia and placental dna
methylation variations at the leptin gene locus and cord blood leptin levels.
Int. J. Mol. Sci. 2020;21(1):329.
41. Kadakia R, Zheng Y, Zhang Z,
Zhang W, Hou L, Josefson JL. Maternal pre-pregnancy BMI downregulates neonatal
cord blood LEP methylation. Pediatr. Obes. 2017;12:57-64.
42. Mansell T, Ponsonby AL,
Collier F, Burgner D, Vuillermin P, Lange K, et al. Genetic variation,
intrauterine growth, and adverse pregnancy conditions predict leptin gene DNA
methylation in blood at birth and 12 months of age. Int J Obes (Lond).
2020;44(1):45-56.
43. Côté S, Gagné-Ouellet V, Guay
SP, Allard C, Houde AA, Perron P, et al. PPARGC1α gene DNA methylation
variations in human placenta mediate the link between maternal hyperglycemia
and leptin levels in newborns. Clin. Epigenetics. 2016;8(1):1-3.
44. Nogues P, Dos Santos E, Jammes
H, Berveiller P, Arnould L, Vialard F, et al. Maternal obesity influences
expression and DNA methylation of the adiponectin and leptin systems in human
third-trimester placenta. Clin. Epigenetics. 2019;11(1):1-8.
45. Antoun E, Titcombe P,
Dalrymple K, Kitaba NT, Barton SJ, Flynn A, et al. DNA methylation signatures
in cord blood associated with birthweight are enriched for dmCpGs previously
associated with maternal hypertension or pre-eclampsia, smoking and folic acid
intake. Epigenetics. 2021 Apr 30:1-7.
46. McCullough LE, Mendez MA,
Miller EE, Murtha AP, Murphy SK, Hoyo C. Associations between prenatal physical
activity, birth weight, and DNA methylation at genomically imprinted domains in
a multiethnicnewborn cohort. Epigenetics. 2015;10(7):597-606.
47. Tobi EW, Goeman JJ, Monajemi
R, Gu H, Putter H, Zhang Y, et al. DNAmethylation signatures link prenatal
famine exposure to growth and metabolism. Nat Commun. 2014;5:5592.
48. Dominguez-Salas P, Moore SE,
Baker MS, Bergen AW, Cox SE, Dyer RA, et al. Maternal nutrition at conception
modulates DNA methylation of human metastable epialleles. Nat Commun.
2014;5:3746
49. Martin CL, Jima D, Sharp GC,
McCullough LE, Park SS, Gowdy KM, et al. Maternal pre-pregnancy obesity,
offspring cord blood DNA methylation, and offspring cardiometabolic health in
early childhood: an epigenome-wide association study. Epigenetics.
2019;14(4):325-40.
50. Wiebe HW, Boulé NG, Chari R,
Davenport MH. The effect of supervised prenatal exercise on fetal growth: a
meta-analysis. Obstet. Gynecol. 2015;125(5):1185-94.
51. Sacco MR, De Castro NP,
Euclydes VL, Souza JM, Rondó PH. Birth weight, rapid weight gain in infancy and
markers of overweight and obesity in childhood. Eur. J. Clin. Nutr.
2013;67(11):1147-53.
52. Rotevatn TA, Overgaard C,
Melendez-Torres GJ, Mortensen RN, Ullits LR, Høstgaard AM, et al. Infancy
weight gain, parental socioeconomic position, and childhood overweight and
obesity: a Danish register-based cohort study. BMC Public Health.
2019;19(1):1-3.
53. Lu Y, Pearce A, Li L. Weight
gain in early years and subsequent body mass index trajectories across birth
weight groups: a prospective longitudinal study. Eur. J. Public Health.
2020;30(2):316-22.
54. Lucas A. Long-term programming
effects of early nutrition—implications for the preterm infant. J. Perinatol.
2005; 25(2):S2-6.
55. Hokken-Koelega A, van Pareren
Y, Arends N. Effects of growth hormone treatment on cognitive function and head
circumference in children born small for gestational age. Horm. Res. Paediatr.
2005;64(3):95-9.
56. Singhal A, Lucas A. Early origins
of cardiovascular disease: is there a unifying hypothesis? The Lancet. 2004;
363(9421):1642-5.
57. Singhal A, Fewtrell M, Cole
TJ, Lucas A. Low nutrient intake and early growth for later insulin resistance
in adolescents born preterm. The Lancet. 2003; 361(9363):1089-97.
58. Ong KK. Catch-up growth in
small for gestational age babies: good or bad?. Current Opinion in
Endocrinology. Diabetes and Obesity. 2007;14(1):30-4.
59. Berti C, Cetin I, Agostoni C,
et al. Pregnancy and infants’ outcome: nutritional and metabolic implications.
Crit Rev Food SciNutr. 2016; 56:82–91.
60. Koletzko B, Brands B,
Chourdakis M, et al. The Power of Programming and The Early Nutrition project:
opportunities for health promotion by nutrition during the first thousand days
of life and beyond. Ann Nutr Metab. 2014; 64:141–150.
61. Dodd JM, Turnbull D, McPhee
AJ, Deussen AR, Grivell RM, Yelland LN, et al. Antenatal lifestyle advice for
women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348.
62. Poston L, Bell R, Croker H,
Flynn AC, Godfrey KM, Goff L, et al. Effect of a behavioural intervention in
obese pregnant women (the UPBEAT study): a multicentre, randomised controlled
trial. Lancet Diabetes Endocrinol.2015;3(10):767-77.
63. Catalano P, Demouzon SH.
Maternal obesity and metabolic risk to the offspring: why lifestyle
interventions may have not achieved the desired outcomes. Int J Obes (Lond).
2015;39(4):642-9.
64. Patel N, Godfrey KM, Pasupathy
D, Levin J, Flynn AC, Hayes L, et al: Infant adiposity following a randomised
controlled trial of a behavioural intervention in obese pregnancy. Int J Obes
(Lond) 2017, Epub ahead of print.
65. Rasmussen KM, Yaktine AE.
Institute of Medicine (US). Committee to Reexamine IOM Pregnancy Weight
Guidelines. Weight gain during pregnancy: reexamining the guidelines.
66. Institute of Medicine,
National Research Council. Subcommittee on Nutrition During Lactation,
Institute of Medicine (US). Subcommittee on Nutrition during Lactation,
Institute of Medicine (US). Subcommittee on Lactation, United States. Health
Resources, Services Administration, Institute of Medicine Staff, États-Unis.
Health Resources, Services Administration, Committee on Nutritional Status
During Pregnancy, Lactation. Nutrition during lactation.
67. Nascimento SL, Pudwell J,
Surita FG, Adamo KB, Smith GN. The effect of physical exercise strategies on weight
loss in postpartum women: a systematic review and meta-analysis. Int J Obes
(Lond). 2014;38(5):626-35.
68. Lovelady C. Balancing exercise
and food intake with lactation to promote post-partum weight loss. Proceedings
of the Nutrition Society. 2011;70(2):181-4.
69. Adegboye AR, Linne YM. Diet or
exercise, or both, for weight reduction in women after childbirth. Cochrane
Database of Systematic Reviews. 2013(7).
70. Ma RC, Schmidt MI, Tam WH,
McIntyre HD, Catalano PM. Clinical management of pregnancy in the obese mother:
before conception, during pregnancy, and post partum. Lancet Diabetes
Endocrinol. 2016;4(12):1037-49.
71. Maggard MA, Yermilov I, Li Z,
Maglione M, Newberry S, Suttorp M, et al. Pregnancy and fertility following
bariatric surgery: a systematic review. JAMA. 2008;300(19):2286-96.
72. Von Kries R, Koletzko B,
Sauerwald T, Von Mutius E, Barnert D, Grunert V, Von Voss H. Breast feeding and
obesity: cross sectional study. BMJ. 1999;319(7203):147-50.
73. Yan J, Liu L, Zhu Y, Huang G,
Wang PP. The association between breastfeeding and childhood obesity: a
meta-analysis. BMC public health. 2014;14(1):1-1.
74. Mihrshahi S, Battistutta D,
Magarey A, Daniels LA. Determinants of rapid weight gain during infancy: baseline
results from the NOURISH randomised controlled trial. BMC pediatr.
2011;11(1):1-8.
75. Savage JS, Birch LL, Marini M,
Anzman-Frasca S, Paul IM. Effect of the INSIGHT responsive parenting
intervention on rapid infant weight gain and overweight status at age 1 year: a
randomized clinical trial. JAMA pediatrics. 2016;170(8):742-9.
76. Consultation WE. Appropriate
body-mass index for Asian populations and its implications for policy and
intervention strategies. Lancet (London, England). 2004;363(9403):157-63.
77. Misra A. Ethnic-specific
criteria for classification of body mass index: a perspective for Asian Indians
and American Diabetes Association position statement. Diabetes Technol. Ther. 2015;17(9):667-71.
78. Kramer CK, Zinman B,
Retnakaran R. Are metabolically healthy overweight and obesity benign
conditions? A systematic review and meta-analysis. Intern. Med.
2013;159(11):758-69.
79. Fortin‐Miller S, Plonka B,
Gibbs H, Christifano D, Hull H. Prenatal interventions and the development of
childhood obesity. Pediatr. Obes. 2023;18(2):12981.
80. Gortmaker SL, Swinburn BA,
Levy D, Carter R, Mabry PL, Finegood DT, Huang T, Marsh T, Moodie ML. Changing
the future of obesity: science, policy, and action. The Lancet.
2011;378(9793):838-47.
81. WHO guidelines on physical
activity and sedentary behavior 25
November 2020 | Guideline Available at
https://www.who.int/publications/i/item/9789240015128.